124 related articles for article (PubMed ID: 33821203)
1. Phase I study on the safety and preliminary efficacy of allogeneic mesenchymal stem cells in hypoxic-ischemic encephalopathy.
Kabataş S; Civelek E; Kaplan N; Savrunlu EC; Sezen GB; Chasan M; Can H; Genç A; Akyuva Y; Boyalı O; Diren F; Karaoz E
World J Exp Med; 2021 Mar; 11(2):17-29. PubMed ID: 33821203
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of allogeneic mesenchymal stem cells in pediatric hypoxic-ischemic encephalopathy: Phase I study.
Kabatas S; Civelek E; Savrunlu EC; Kaplan N; Boyalı O; Diren F; Can H; Genç A; Akkoç T; Karaöz E
World J Stem Cells; 2021 May; 13(5):470-484. PubMed ID: 34136076
[TBL] [Abstract][Full Text] [Related]
3. Wharton's Jelly-Derived Mesenchymal Stem Cell Transplantation in a Patient with Hypoxic-Ischemic Encephalopathy: A Pilot Study.
Kabataş S; Civelek E; İnci Ç; Yalçınkaya EY; Günel G; Kır G; Albayrak E; Öztürk E; Adaş G; Karaöz E
Cell Transplant; 2018 Oct; 27(10):1425-1433. PubMed ID: 30203688
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficiency of Wharton's Jelly-derived mesenchymal stem cell administration in patients with traumatic brain injury: First results of a phase I study.
Kabatas S; Civelek E; Boyalı O; Sezen GB; Ozdemir O; Bahar-Ozdemir Y; Kaplan N; Savrunlu EC; Karaöz E
World J Stem Cells; 2024 Jun; 16(6):641-655. PubMed ID: 38948099
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of human umbilical cord mesenchymal stem cells on neonatal rat hypoxic-ischemic encephalopathy.
Zhang X; Zhang Q; Li W; Nie D; Chen W; Xu C; Yi X; Shi J; Tian M; Qin J; Jin G; Tu W
J Neurosci Res; 2014 Jan; 92(1):35-45. PubMed ID: 24265136
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effects of human umbilical cord mesenchymal stem cells transplantation on hypoxic ischemic encephalopathy.
Xie B; Gu P; Wang W; Dong C; Zhang L; Zhang J; Liu H; Qiu F; Han R; Zhang Z; Yan B
Am J Transl Res; 2016; 8(7):3241-50. PubMed ID: 27508046
[TBL] [Abstract][Full Text] [Related]
7. Comparative Analysis of the Results of Stroke Treatment With Multiple Administrations of Wharton's Jelly Mesenchymal Stem Cells-Derived HE-ATMP and Standard Conservative Treatment: Case Series Study.
Milczarek O; Swadźba J; Swadźba P; Starowicz-Filip A; Krzyżewski RM; Kwiatkowski S; Majka M
Cell Transplant; 2023; 32():9636897231195145. PubMed ID: 37644776
[TBL] [Abstract][Full Text] [Related]
8. Wharton's jelly or bone marrow mesenchymal stromal cells improve cardiac function following myocardial infarction for more than 32 weeks in a rat model: a preliminary report.
López Y; Lutjemeier B; Seshareddy K; Trevino EM; Hageman KS; Musch TI; Borgarelli M; Weiss ML
Curr Stem Cell Res Ther; 2013 Jan; 8(1):46-59. PubMed ID: 23270633
[TBL] [Abstract][Full Text] [Related]
9. Isolation and Characterization of Feline Wharton's Jelly-Derived Mesenchymal Stem Cells.
Seo MS; Kang KK; Oh SK; Sung SE; Kim KS; Kwon YS; Yun S
Vet Sci; 2021 Feb; 8(2):. PubMed ID: 33562192
[TBL] [Abstract][Full Text] [Related]
10. Wharton's jelly-derived mesenchymal stem cells attenuate sepsis-induced organ injury partially via cholinergic anti-inflammatory pathway activation.
Capcha JMC; Rodrigues CE; Moreira RS; Silveira MD; Dourado P; Dos Santos F; Irigoyen MC; Jensen L; Garnica MR; Noronha IL; Andrade L; Gomes SA
Am J Physiol Regul Integr Comp Physiol; 2020 Jan; 318(1):R135-R147. PubMed ID: 31596111
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic mesenchymal stem cells may be a viable treatment modality in cerebral palsy.
Boyalı O; Kabatas S; Civelek E; Ozdemir O; Bahar-Ozdemir Y; Kaplan N; Savrunlu EC; Karaöz E
World J Clin Cases; 2024 Mar; 12(9):1585-1596. PubMed ID: 38576742
[TBL] [Abstract][Full Text] [Related]
12. Human umbilical cord Wharton's Jelly-derived mesenchymal stem cells differentiation into nerve-like cells.
Ma L; Feng XY; Cui BL; Law F; Jiang XW; Yang LY; Xie QD; Huang TH
Chin Med J (Engl); 2005 Dec; 118(23):1987-93. PubMed ID: 16336835
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of canine Wharton's jelly-derived mesenchymal stem cells.
Seo MS; Park SB; Kang KS
Cell Transplant; 2012; 21(7):1493-502. PubMed ID: 22732242
[TBL] [Abstract][Full Text] [Related]
14. Pressure Stimuli Improve the Proliferation of Wharton's Jelly-Derived Mesenchymal Stem Cells under Hypoxic Culture Conditions.
Park SE; Kim H; Kwon S; Choi SJ; Oh SY; Ryu GH; Jeon HB; Chang JW
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993025
[TBL] [Abstract][Full Text] [Related]
15. hUC-MSCs Exert a Neuroprotective Effect via Anti-apoptotic Mechanisms in a Neonatal HIE Rat Model.
Xu J; Feng Z; Wang X; Xiong Y; Wang L; Ye L; Zhang H
Cell Transplant; 2019 Dec; 28(12):1552-1559. PubMed ID: 31512502
[TBL] [Abstract][Full Text] [Related]
16. Distribution of Embryonic Stem Cell-Derived Mesenchymal Stem Cells after Intravenous Infusion in Hypoxic-Ischemic Encephalopathy.
Lee SH; Choung JS; Kim JM; Kim H; Kim M
Life (Basel); 2023 Jan; 13(1):. PubMed ID: 36676176
[TBL] [Abstract][Full Text] [Related]
17. Human Wharton's jelly mesenchymal stem cell secretome display antiproliferative effect on leukemia cell line and produce additive cytotoxic effect in combination with doxorubicin.
Hendijani F; Javanmard SH; Sadeghi-aliabadi H
Tissue Cell; 2015 Jun; 47(3):229-34. PubMed ID: 25779671
[TBL] [Abstract][Full Text] [Related]
18. Neural differentiation of human Wharton's jelly-derived mesenchymal stem cells improves the recovery of neurological function after transplantation in ischemic stroke rats.
Zhang L; Wang LM; Chen WW; Ma Z; Han X; Liu CM; Cheng X; Shi W; Guo JJ; Qin JB; Yang XQ; Jin GH; Zhang XH
Neural Regen Res; 2017 Jul; 12(7):1103-1110. PubMed ID: 28852392
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of human mesenchymal stem cells (MSC) to dopaminergic neurons: A comparison between Wharton's Jelly and olfactory mucosa as sources of MSCs.
Alizadeh R; Bagher Z; Kamrava SK; Falah M; Ghasemi Hamidabadi H; Eskandarian Boroujeni M; Mohammadi F; Khodaverdi S; Zare-Sadeghi A; Olya A; Komeili A
J Chem Neuroanat; 2019 Mar; 96():126-133. PubMed ID: 30639339
[TBL] [Abstract][Full Text] [Related]
20. Extracellular Vesicles Derived from Wharton's Jelly Mesenchymal Stem Cells Prevent and Resolve Programmed Cell Death Mediated by Perinatal Hypoxia-Ischemia in Neuronal Cells.
Joerger-Messerli MS; Oppliger B; Spinelli M; Thomi G; di Salvo I; Schneider P; Schoeberlein A
Cell Transplant; 2018 Jan; 27(1):168-180. PubMed ID: 29562785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
